ALFA Filings
Every announcement, straight from the exchange
Every Kilitch Drugs(I) other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Kilitch Drugs (India) Limited submitted its quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026.
Kilitch Drugs filed its Monitoring Agency Report for the quarter ended June 30, 2026, concerning its Rights Issue proceeds of Rs. 49.92 Crore.
Kilitch Drugs (India) Limited submitted its Annual Secretarial Compliance Report for the financial year 2026. This mandatory regulatory filing confirms the company's adherence to SEBI governance standards.